| Literature DB >> 32448277 |
Teresa-Rose Kattackal1, Sabrina Cavallo2, Lucie Brosseau3, Aditi Sivakumar4, Michael J Del Bel3, Michelle Dorion3, Erin Ueffing4, Karine Toupin-April5,6,7.
Abstract
BACKGROUND: The reporting quality of physical activity (PA) programs in randomized controlled trials (RCTs) for the management of juvenile idiopathic arthritis (JIA) remains unknown. This study aimed to assess and compare the reporting quality of PA programs in RCTs for the management of JIA using three difference standardized assessment tools, and to describe the elements that were similar and different between these tools.Entities:
Keywords: Juvenile idiopathic arthritis; Physical activity programs; Randomized controlled trials; Reporting quality
Mesh:
Year: 2020 PMID: 32448277 PMCID: PMC7245815 DOI: 10.1186/s12969-020-00434-9
Source DB: PubMed Journal: Pediatr Rheumatol Online J ISSN: 1546-0096 Impact factor: 3.054
Fig. 1Study flow diagram (Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA)) for selected RCTs. This PRISMA flow chart is developed using the “PRISMA Statement” referenced in: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6 (7): e1000097.10.1371/journal.pmed.1000097
Individual, total and percentage consensus scores for the TIDieR checklist, the CERT checklist, and the CONTENT scale
| Author / Year | TIDieR | CERT | CONTENT | Scoring Variation (%) |
|---|---|---|---|---|
| Baydogan (2015) [ | 8 (66.7) | 11 (57.9) | 6 (66.7) | 8.8 |
| Bayraktar (2019) [ | 11 (91.6) | 13 (68.4) | 8 (88.9) | 23.2 |
| Eid (2016) [ | 6 (50.0) | 6 (31.6) | 4 (44.5) | 18.4 |
| Elnaggar (2016) [ | 9 (75.0) | 8 (42.1) | 6 (66.7) | 32.9 |
| El Aziz (2017) [ | 7 (58.3) | 5 (26.3) | 5 (55.6) | 32 |
| Mendonca (2013) [ | 10 (83.3) | 16 (84.2) | 7 (77.8) | 6.4 |
| Sandstedt (2013) [ | 8 (66.7) | 7 (36.8) | 4 (44.5) | 29.9 |
| Singh-Grewal (2007) [ | 8 (66.7) | 12 (63.2) | 8 (88.9) | 25.7 |
| Takken (2003) [ | 7 (58.3) | 8 (42.1) | 6 (66.7) | 24.6 |
| Tarakci (2012) [ | 11 (91.6) | 15 (78.9) | 9 (100.0) | 21.1 |
| 8.5 (± 1.7) | 10.1 (± 3.8) | 6.3 (± 1.7) | ________ | |
| 70.8 (±14.3) | 53.2 (±20.2) | 70.0 (±18.9) | 22.3 (±9.0) |
Fig. 2Percentage of RCTs (n = 10) which reported each TIDieR checklist item (see Appendix 2: item descriptions)
Fig. 3Percentage of RCTs (n = 10) which reported each CERT checklist item (see Appendix 2: item descriptions)
Fig. 4Percentage of RCTs (n = 10) which reported each CONTENT scale item (see Appendix 2: item descriptions)
Individual RCT TIDieR checklist scores based on reviewer consensus
| Author (Year) | TIDieR Items | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| BRIEF NAME | WHY | WHAT: Materials | WHAT: Procedure | WHO: Intervention provider | HOW: Mode of delivery | WHERE | WHEN, HOW: Duration | TAILORING/ PROGRESSION | MODIFICATION | HOW WELL: Measure of adherence | HOW WELL: Actual adherence | |
| Baydogan (2015) [ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 |
| Bayraktar (2019) [ | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Eid (2016) [ | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| Elnaggar (2016) [ | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
| El Aziz (2017) [ | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Mendonca (2013) [ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 |
| Sandstedt (2013) [ | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
| Singh-Grewal (2007) [ | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 |
| Takken (2003) [ | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 |
| Tarakci (2012) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
0: item is not reported; 1: item is reported
Individual RCT CERT checklist scores based on reviewer consensus
| Author (Year) | CERT Items | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7A | 7B | 8 | 9 | 10 | 11 | 12 | 13 | 14A | 14B | 15 | 16A | 16B | |
| WHAT: Materials | WHO: Intervention provider | HOW: Individually or group | HOW: Supervised | HOW: Measure of adherence | HOW: Motivation strategy | HOW: Progression through program | HOW: Progressions | HOW: Exercise description | HOW: Home program component | HOW: Non-exercise components | HOW: Adverse events | WHERE: Location | WHEN, HOW MUCH | TAILORING: Generic or Individual | TAILORING: Individual tailoring | TAILORING: Starting level | HOW WELL: Adherence to intervention | HOW WELL: Delivered as planned | |
| Baydogan (2015) [ | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Bayraktar (2019) [ | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Eid (2016) [ | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Elnaggar (2016) [ | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| El Aziz (2017) [ | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| Mendonca (2013) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Sandstedt (2013) [ | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 |
| Singh-Grewal (2007) [ | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 |
| Takken (2003) [ | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Tarakci (2012) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
0: item is not reported; 1: item is reported
Individual RCT CONTENT scale scores based on reviewer consensus
| Author (Year) | CONTENT Items | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
| WHO: Patient selection | WHO: Adequate patient selection | WHO, WHERE: Therapist and setting | WHY: A-priori aims | WHY: Content and intensity rationale | WHAT: Intensity | HOW: Monitored and adjusted | HOW: Personalized and contextualized | HOW: Adherence | |
| Baydogan (2015) [ | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
| Bayraktar (2019) [ | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Eid (2016) [ | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
| Elnaggar (2016) [ | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 |
| El Aziz (2017) [ | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| Mendonca (2013) [ | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Sandstedt (2013) [ | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Singh-Grewal (2007) [ | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Takken (2003) [ | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| Tarakci (2012) [ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
0: item is not reported; 1: item is reported